NasdaqGS - Nasdaq Real Time Price USD
LENZ Therapeutics, Inc. (LENZ)
26.34
+0.47
+(1.82%)
At close: May 9 at 4:00:00 PM EDT
26.34
0.00
(0.00%)
After hours: May 9 at 4:20:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 3 | 4 |
| Avg. Estimate | -0.43 | -0.28 | -2.43 | -2.77 |
| Low Estimate | -0.49 | -0.28 | -3 | -3.89 |
| High Estimate | -0.37 | -0.28 | -1.63 | -1.16 |
| Year Ago EPS | -0.4 | -0.38 | -2.34 | -2.43 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 8 | 8 |
| Avg. Estimate | -- | 5M | 7.63M | 49.19M |
| Low Estimate | -- | -- | 6M | 41.69M |
| High Estimate | -- | 10M | 11.33M | 56.74M |
| Year Ago Sales | -- | -- | -- | 7.63M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 544.87% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.67 | -0.43 | -0.4 | -0.32 |
| EPS Actual | -0.4 | -0.38 | -0.46 | -0.53 |
| Difference | 0.27 | 0.05 | -0.06 | -0.21 |
| Surprise % | 40.30% | 11.35% | -15.65% | -65.63% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.43 | -0.28 | -2.43 | -2.77 |
| 7 Days Ago | -0.37 | -0.28 | -2.89 | -2.77 |
| 30 Days Ago | 0 | 0 | -3.32 | -3.3 |
| 60 Days Ago | -0.49 | 0 | -1.79 | -2.3 |
| 90 Days Ago | -0.49 | 0 | -1.79 | -2.3 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LENZ | -7.50% | 26.32% | -3.70% | -14.06% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/16/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 4/14/2025 |
| Maintains | Citigroup: Buy to Buy | 3/20/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/7/2024 |
| Initiated | Raymond James: Outperform | 9/27/2024 |
Related Tickers
ABOS Acumen Pharmaceuticals, Inc.
0.9801
-1.99%
DSGN Design Therapeutics, Inc.
3.5000
-0.57%
REPL Replimune Group, Inc.
7.71
-0.77%
URGN UroGen Pharma Ltd.
10.38
-2.72%
ACRS Aclaris Therapeutics, Inc.
1.2600
-3.82%
TARA Protara Therapeutics, Inc.
3.2400
-3.86%
NUVL Nuvalent, Inc.
69.85
-2.44%
CKPT Checkpoint Therapeutics, Inc.
4.1700
+0.72%
ITOS iTeos Therapeutics, Inc.
6.67
-0.52%
NGNE Neurogene Inc.
14.73
-1.80%